脑出血的微创手术治疗
这项Meta分析检索主要数据库至2017年10月,纳入15项高质量随机对照试验共2152例幕上自发性脑出血患者,比较微创手术(总体、内镜手术、立体定向溶栓)与常规治疗及开颅手术的死亡或依赖及死亡结局,发现选择性患者可从微创手术获益,特定技术和清除时机亚组分析亦支持该获益。
要点
- 微创手术总体与常规治疗相比,死亡或依赖的OR为0.46(0.36-0.57),死亡的OR为0.59(0.45-0.76)。
- 内镜手术与常规治疗相比,死亡或依赖的OR为0.40(0.25-0.66),死亡的OR为0.37(0.20-0.67)。
- 立体定向溶栓与常规治疗相比,死亡或依赖的OR为0.47(0.34-0.65),死亡的OR为0.76(0.56-1.04)。
核心结论
- 该Meta分析表明,选择性幕上脑出血患者可从微创手术而非其他治疗中获益。
- 在分析特定技术和清除时机亚组时,该获益效应仍然成立。
研究设计与样本
- 检索Pubmed、CENTRAL、Embase、Web of Science、Scopus、ICTRP、Internet Stroke Center及CNKI等主要科学数据库,检索时间为2017年10月。
- 纳入15项高质量随机对照试验,共2152例幕上自发性脑出血患者。
- 主要结局定义为随访结束时死亡或依赖,次要结局定义为死亡。
主要发现
- 微创手术总体与常规治疗相比,主要结局OR为0.46(0.36-0.57),次要结局OR为0.59(0.45-0.76)。
- 内镜手术与常规治疗相比,主要结局OR为0.40(0.25-0.66),次要结局OR为0.37(0.20-0.67)。
- 立体定向溶栓与常规治疗相比,主要结局OR为0.47(0.34-0.65),次要结局OR为0.76(0.56-1.04)。
- 微创手术与开颅手术相比,主要结局OR为0.44(0.29-0.67),次要结局OR为0.56(0.37-0.84)。
- 按清除时间亚组分析,24小时内清除者主要结局OR为0.36(0.22-0.59),次要结局OR为0.59(0.34-1.00);72小时内清除者主要结局OR为0.49(0.38-0.63),次要结局OR为0.57(0.43-0.76)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Minimally invasive surgery (MIS) for intracerebral hemorrhage (ICH) has been evaluated in numerous clinical trials. Although meta-analyses for this strategy have been performed in the past, recent trials add important information to results of the comparison and permit strategy-specific analyses, including evaluation of endoscopic evacuation and stereotactic thrombolysis. Methods- Major scientific databases including but not limited to Pubmed, the CENTRAL (Cochrane Central Register of Controlled Trials), Embase, Web of Science, Scopus, the ICTRP (International Clinical Trials Registry Platform), the Internet Stroke Center, and the CNKI (Chinese National Knowledge Infrastructure) were searched in October of 2017 for randomized controlled trials of MIS treatment of supratentorial spontaneous ICH. The primary outcome was defined as death or dependence at the end of follow-up, and the secondary outcome was defined as death. Results- The initial search yielded 958 reports, which were reduced to 15 high-quality randomized controlled trials involving 2152 patients. We analyzed odds ratios for MIS overall, endoscopic surgery, and stereotactic thrombolysis compared with conventional treatment, including medical treatment and conventional craniotomy. The odds ratio and CIs of the primary and secondary outcomes were 0.46 (0.36-0.57) and 0.59 (0.45-0.76) for MIS versus conventional treatment; 0.40 (0.25-0.66) and 0.37 (0.20-0.67) for endoscopic surgery versus conventional treatment; 0.47 (0.34-0.65) and 0.76 (0.56-1.04) for stereotactic thrombolysis versus conventional treatment; and 0.44 (0.29-0.67) and 0.56 (0.37-0.84) for MIS versus craniotomy. We also conducted subgroup analyses focusing on time to evacuation for MIS versus conventional treatment and found 0.36 (0.22-0.59) and 0.59 (0.34-1.00) for evacuations performed within 24 hours and 0.49 (0.38-0.63) and 0.57 (0.43-0.76) for evacuations performed within 72 hours. Conclusions- This meta-analysis demonstrates that select patients with supratentorial ICH benefit from MIS over other treatments. This beneficial effect remains true when analyzing specific techniques and evacuation timing subgroups.
引用
- Scaggiante J, Zhang X, Mocco J, et al. Minimally Invasive Surgery for Intracerebral Hemorrhage. Stroke. 2018. PMID: 30355183. doi:10.1161/STROKEAHA.118.020688
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。